Fuller Industries, Inc
FDA inspection history in Great Bend, Kansas, 2023 to 2025
- 2
- Form 483s
- 1
- Warning letter
Every document, by year
- Form 483
- Warning letter
2023: one warning letter and one Form 483; 2025: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2023–25Two Form 483s and one warning letter, at Great Bend, Kansas.
- 2023The longest 483 on file: 7 observations over 4 pages at Great Bend, Kansas.
Cited most
Across all Fuller Industries observations on file
- 21 CFR 211.160(b)General requirements2
- 21 CFR 211.166(a)Stability testing2
- 21 CFR 211.84(d)(2)Testing and approval or rejection of components, drug product containers, and closures2
- 21 CFR 211.100(a)Written procedures; deviations1
- 21 CFR 211.165(f)Testing and release for distribution1
The complete Fuller Industries file.
All 3 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
Great Bend, Kansas
Two Form 483s and one warning letter · 2023 to 2025 · 12 observations
Latest: Form 483, Mar 26, 2025 →
Documents
3 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2025-03-26 | 483 Form 483 | Great Bend, Kansas | 5 | $99 |
| 2023-06-28 | Warning letter Warning letter | Great Bend, Kansas | — | $99 |
| 2023-02-17 | 483 Form 483 | Great Bend, Kansas | 7 | $99 |
Investigators on these documents
FEI number 1922337 · most recent document Mar 26, 2025
About Fuller Industries, Inc
How many FDA Form 483s has Fuller Industries, Inc received?
FDA Intel has 2 Form 483s on file for Fuller Industries, Inc; the most recent is dated Mar 26, 2025.
When was Fuller Industries, Inc last inspected by FDA?
The most recent FDA inspection document on file for Fuller Industries, Inc is a Form 483 dated Mar 26, 2025, for the site in Great Bend, Kansas.
What did FDA cite at Fuller Industries, Inc?
The regulations cited most in the observations on file for Fuller Industries, Inc are 21 CFR 211.160(b) (General requirements), 2 times; 21 CFR 211.166(a) (Stability testing), 2 times; 21 CFR 211.84(d)(2) (Testing and approval or rejection of components, drug product containers, and closures), 2 times.
Has Fuller Industries, Inc received an FDA warning letter?
Yes. FDA Intel has 1 FDA warning letter on file for Fuller Industries, Inc; the most recent is dated Jun 28, 2023.